E-LIB Suche - Ergebnisse für: Finke, Paul E.

1

Optimization of Preclinical Metabolism for Somatostatin Rec..:

Liu, Weiguo ; Hussain, Zahid ; Zang, Yi...
ACS Medicinal Chemistry Letters. 9 (2018) 11 - p. 1088-1093 , 2018

Link: https://doi.org/10.1021/..

2

Spasmolytic Polypeptide-Expressing Metaplasia (SPEM) Does N..:

Nam, Ki Taek ; O'Neal, Ryan L. ; Coffey, Robert J....
Gastroenterology. 140 (2011) 5 - p. S-48 , 2011

Link: https://doi.org/10.1016/..

3

Mature Chief Cells Are Cryptic Progenitors for Metaplasia i..:

Nam, Ki Taek ; Lee, Hyuk–Joon ; Sousa, Josane F....
Gastroenterology. 139 (2010) 6 - p. 2028-2037.e9 , 2010

Link: https://doi.org/10.1053/..

4

Characterization of a novel and selective cannabinoid CB1 r..:

Shearman, Lauren P. ; Stribling, D. Sloan ; Camacho, Ramon E....
European Journal of Pharmacology. 579 (2008) 1-3 - p. 215-224 , 2008

Link: https://doi.org/10.1016/..

5

Cyclopentane-based human NK1 antagonists. Part 1: Discovery..:

Finke, Paul E. ; Meurer, Laura C. ; Levorse, Dorothy A....
Bioorganic & Medicinal Chemistry Letters. 16 (2006) 17 - p. 4497-4503 , 2006

Link: https://doi.org/10.1016/..

6

Cyclopentane-based human NK1 antagonists. Part 2: Developme..:

Meurer, Laura C. ; Finke, Paul E. ; Owens, Karen A....
Bioorganic & Medicinal Chemistry Letters. 16 (2006) 17 - p. 4504-4511 , 2006

Link: https://doi.org/10.1016/..

7

Synthesis and SAR of 5,6-diarylpyridines as human CB1 inver..:

Meurer, Laura C. ; Finke, Paul E. ; Mills, Sander G....
Bioorganic & Medicinal Chemistry Letters. 15 (2005) 3 - p. 645-651 , 2005

Link: https://doi.org/10.1016/..

8

Corrigendum to "Synthesis and SAR of 5,6-diarylpyridines as..:

Meurer, Laura C. ; Finke, Paul E. ; Mills, Sander G....
Bioorganic & Medicinal Chemistry Letters. 15 (2005) 6 - p. 1755 , 2005

Link: https://doi.org/10.1016/..

9

Synthesis and activity of 4,5-diarylimidazoles as human CB1..:

Plummer, Christopher W. ; Finke, Paul E. ; Mills, Sander G....
Bioorganic & Medicinal Chemistry Letters. 15 (2005) 5 - p. 1441-1446 , 2005

Link: https://doi.org/10.1016/..

10

Syntheses and biological evaluation of 5-(piperidin-1-yl)-3..:

Shankaran, K. ; Donnelly, Karla L. ; Shah, Shrenik K....
Bioorganic & Medicinal Chemistry Letters. 14 (2004) 13 - p. 3589-3593 , 2004

Link: https://doi.org/10.1016/..

11

CCR5 Antagonists: 3-(Pyrrolidin-1-yl)propionic Acid Analog..:

Lynch, Christopher L. ; Hale, Jeffrey J. ; Budhu, Richard J....
Organic Letters. 5 (2003) 14 - p. 2473-2475 , 2003

Link: https://doi.org/10.1021/..

12

Binding of 2-Aryl-4-(piperidin-1-yl)butanamines and 1,3,4-T..:

Castonguay, Laurie A. ; Weng, Youmin ; Adolfsen, William...
Biochemistry. 42 (2003) 6 - p. 1544-1550 , 2003

Link: https://doi.org/10.1021/..

13

Expeditious synthesis of tri-substituted cyclopentane deriv..:

Desai, Ranjit C ; Cicala, Peter ; Meurer, Laura C.
Tetrahedron Letters. 43 (2002) 26 - p. 4569-4570 , 2002

Link: https://doi.org/10.1016/..

14

Design, synthesis, and SAR of heterocycle-containing antago..:

Kim, Dooseop ; Wang, Liping ; Caldwell, Charles G....
Bioorganic & Medicinal Chemistry Letters. 11 (2001) 24 - p. 3103-3106 , 2001

Link: https://doi.org/10.1016/..

15

Antagonists of the human CCR5 receptor as anti-HIV-1 agents..:

Finke, Paul E. ; Oates, Bryan ; Mills, Sander G....
Bioorganic & Medicinal Chemistry Letters. 11 (2001) 18 - p. 2475-2479 , 2001

Link: https://doi.org/10.1016/..